Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer

Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer Archives of Gynecology and Obstetrics (2018) 297:1067–1068 https://doi.org/10.1007/s00404-018-4705-9 CORRESPONDENCE Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer 1 2 1,3 1 G. Corso  · B. Bonanni  · P. Veronesi  · V. Galimberti Received: 12 October 2017 / Accepted: 18 January 2018 / Published online: 3 February 2018 © Springer-Verlag GmbH Germany, part of Springer Nature 2018 Dear Editor, In this study, unaffected individual carrying S838G CDH1 germline missense mutation and BRCA negative We read with interest the recent results reported by Stuebs (CDH1+/BRCA −) seems to fulfill a different inherited et  al. [1]. The authors described novel CDH1 germline breast/ovarian cancer syndrome that requires particular alterations in families, apparently not fulfilling the canoni - attention for clinical management. cal clinical criteria established for the Hereditary Diffuse In accordance with the recent literature data, periodic Gastric Cancer (HDGC) syndrome [2]. In particular, in this breast surveillance is required since prophylactic bilateral study, segregation for gastric tumors is rather rare or absent; mastectomy is not indicated [9]. Whenever confirmed the conversely, a high frequency of ovarian and/or breast can- S838G pathogenicity, prophylactic total gastrectomy could cer (BC) was observed. CDH1 genetic screening of 97 BC be considered [2], also in the absence of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Gynecology and Obstetrics Springer Journals

Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer

Loading next page...
 
/lp/springer_journal/mutual-exclusion-of-cdh1-and-brca-germline-mutations-in-the-pathway-of-5oMuq0WLvv
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
Subject
Medicine & Public Health; Gynecology; Obstetrics/Perinatology/Midwifery; Endocrinology; Human Genetics
ISSN
0932-0067
eISSN
1432-0711
D.O.I.
10.1007/s00404-018-4705-9
Publisher site
See Article on Publisher Site

Abstract

Archives of Gynecology and Obstetrics (2018) 297:1067–1068 https://doi.org/10.1007/s00404-018-4705-9 CORRESPONDENCE Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer 1 2 1,3 1 G. Corso  · B. Bonanni  · P. Veronesi  · V. Galimberti Received: 12 October 2017 / Accepted: 18 January 2018 / Published online: 3 February 2018 © Springer-Verlag GmbH Germany, part of Springer Nature 2018 Dear Editor, In this study, unaffected individual carrying S838G CDH1 germline missense mutation and BRCA negative We read with interest the recent results reported by Stuebs (CDH1+/BRCA −) seems to fulfill a different inherited et  al. [1]. The authors described novel CDH1 germline breast/ovarian cancer syndrome that requires particular alterations in families, apparently not fulfilling the canoni - attention for clinical management. cal clinical criteria established for the Hereditary Diffuse In accordance with the recent literature data, periodic Gastric Cancer (HDGC) syndrome [2]. In particular, in this breast surveillance is required since prophylactic bilateral study, segregation for gastric tumors is rather rare or absent; mastectomy is not indicated [9]. Whenever confirmed the conversely, a high frequency of ovarian and/or breast can- S838G pathogenicity, prophylactic total gastrectomy could cer (BC) was observed. CDH1 genetic screening of 97 BC be considered [2], also in the absence of

Journal

Archives of Gynecology and ObstetricsSpringer Journals

Published: Feb 3, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial